ADOLOR CORP 4

4 · ADOLOR CORP · Filed Dec 9, 2011

Insider Transaction Report

Form 4

Period: 2011-12-07

ADOLOR CORPADLR

NASH CLAUDE

Director

Transactions

Disposition from Tender
Adolor Common Stock (ADLR)
2011-12-07−191,109→ 0 total
Exercise/Conversion
Stock Option (right to buy)
2011-12-07−20,000→ 0 total
Exercise: $2.20→ Adolor Common Stock (ADLR) (20,000 underlying)
Exercise/Conversion
Stock Option (right to buy)
2011-12-07−30,000→ 0 total
Exercise: $1.39→ Adolor Common Stock (ADLR) (30,000 underlying)
Exercise/Conversion
Adolor Common Stock (ADLR)
2011-12-07$1.77/sh+30,000$53,100→ 91,109 total
Exercise/Conversion
Stock Option (right to buy)
2011-12-07−30,000→ 0 total
Exercise: $1.77→ Adolor Common Stock (ADLR) (30,000 underlying)
Exercise/Conversion
Stock Option (right to buy)
2011-12-07−20,000→ 0 total
Exercise: $1.60→ Adolor Common Stock (ADLR) (20,000 underlying)
Exercise/Conversion
Adolor Common Stock (ADLR)
2011-12-07$2.20/sh+20,000$44,000→ 111,109 total
Exercise/Conversion
Adolor Common Stock (ADLR)
2011-12-07$1.39/sh+30,000$41,700→ 161,109 total
Exercise/Conversion
Adolor Common Stock (ADLR)
2011-12-07$1.50/sh+30,000$45,000→ 191,109 total
Exercise/Conversion
Adolor Common Stock (ADLR)
2011-12-07$3.73/sh+20,000$74,600→ 61,109 total
Exercise/Conversion
Adolor Common Stock (ADLR)
2011-12-07$1.60/sh+20,000$32,000→ 131,109 total
Exercise/Conversion
Stock Option (right to buy)
2011-12-07−30,000→ 0 total
Exercise: $1.50→ Adolor Common Stock (ADLR) (30,000 underlying)
Exercise/Conversion
Stock Option (right to buy)
2011-12-07−20,000→ 0 total
Exercise: $3.73→ Adolor Common Stock (ADLR) (20,000 underlying)

Footnotes (2)

[F1]Shares are tendered pursuant to the tender offer commenced with respect to the Issuer's shares (the "Offer") at a purchase price of $4.25 per share in cash, plus one non-transferable contingent payment right for each share, which shall represent the right to receive up to $4.50 in cash subject to the fulfillment of certain conditions and/or the attainment of certain milestones, upon the terms and subject to the conditions set forth in the Offer.
[F2]Transaction pertains to the vesting of unvested stock options and the issuance of shares of common stock underlying certain vested stock options, pursuant to the terms of the Agreement and Plan of Merger, dated as of October 24, 2011, by and among the Issuer, FRD Acquisition Corporation and Cubist Pharmaceuticals, Inc. and the related Offer.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT